Nifecard HL pills po with controlled release 30mg №10×3

Nifecard HL 30mg: Controlled-Release Tablets for Effective Blood Pressure Management

Description:

Nifecard HL tablets are a controlled-release formulation of nifedipine, a calcium channel blocker, designed for the treatment of hypertension and angina pectoris.

Benefits:

• Effective Blood Pressure Control: Nifecard HL helps lower blood pressure by relaxing blood vessels, reducing resistance to blood flow, and easing the workload on the heart.
• Relief from Angina Symptoms: By improving blood flow to the heart, Nifecard HL provides relief from chest pain associated with angina pectoris.
• Controlled Release for Long-Lasting Action: The controlled-release formula ensures a steady release of nifedipine, providing up to 24 hours of blood pressure management.

Key Features:

• Modified-release tablets: Ensures gradual and sustained release of nifedipine.
• Film-coated: Provides ease of swallowing and protects the active ingredient.
• Round, biconvex shape: Aids in smooth passage through the digestive tract.
• “NDP 30” embossed: Helps with identification and dosage accuracy.

Storage:

Store Nifecard HL out of reach of children, at a temperature not exceeding 25°C.

Important Information:

• Consult your doctor before taking Nifecard HL, especially if you have any pre-existing health conditions or are taking other medications.
• Do not take Nifecard HL if you are pregnant (up to 20 weeks), breastfeeding, or have a history of hypersensitivity to nifedipine or other 1,4-dihydropyridine derivatives.
• Avoid grapefruit juice while taking Nifecard HL, as it can affect its absorption.
• Nifecard HL should not be crushed or divided.
• Stop taking Nifecard HL gradually, as sudden discontinuation may lead to angina attacks.

Packaging:

Nifecard HL is available in packs of 10 tablets per blister, with 3 blisters per pack.

Learn More:

For detailed information about Nifecard HL, including dosage, side effects, and drug interactions, please consult the patient information leaflet or talk to your healthcare provider.

Disclaimer:

This information is for general knowledge only and should not be considered as medical advice. Always consult a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Keywords:

nifedipine, controlled-release, hypertension, angina pectoris, calcium channel blocker, blood pressure, medication, heart health, cardiovascular, Nifecard HL, NDP 30, tablets, film-coated, modified-release, storage, dosage, side effects, interactions, drug information, patient information leaflet, healthcare provider, disclaimer.